NanoGroup S.A. Logo

NanoGroup S.A.

Develops patented nanotechnology for oncology and transplantology diagnostics and therapies.

NNG | WAR

Overview

Corporate Details

ISIN(s):
PLNNGRP00011 (+3 more)
LEI:
259400HXWEAZUWRLY648
Country:
Poland
Address:
Warszawa Rakowiecka 36, 02-532 Warszawa
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

NanoGroup S.A. is a biotechnology company that develops and commercializes innovative medical solutions based on its unique, patented nanotechnology. The group's research and development work is concentrated on addressing critical medical needs, primarily in the fields of oncology and transplantology. Key projects include the development of nanoformulations for anticancer drugs, a fluid for the storage of organs intended for transplantation, nanoparticles for diagnostics and therapy, and a human blood substitute. The company operates through specialized subsidiaries, such as nanoSanguis and nanoVelos, to advance its distinct technological platforms and bring new medical technologies to market.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-27 17:16
Quarterly Report
Raport 2025Q3
Polish 1.1 MB
2025-11-27 17:10
Quarterly Report
Raport 2025Q3
Polish 1.1 MB
2025-11-21 08:55
Regulatory News Service
Strategia 2026-2028
Polish 2.1 MB
2025-11-21 08:55
Management Discussion and Analysis
Strategia Rozwoju NanoGroup S.A. na lata 2026-2028 - Content (PL)
Polish 2.6 KB
2025-11-17 12:46
Share Issue/Capital Change
Inwestycja pośrednia w AUXILIUS PHARMA S.A. - Content (PL)
Polish 4.8 KB
2025-11-10 17:02
Share Issue/Capital Change
Dopuszczenie i wprowadzenie do obrotu giełdowego Akcji Serii K - Content (PL)
Polish 1.4 KB
2025-11-03 19:31
Registration Form
Oświadczenie KDPW
Polish 176.7 KB
2025-11-03 19:31
Share Issue/Capital Change
Rejestracja w Krajowym Depozycie Papierów Wartościowych akcji serii K - Content…
Polish 1.6 KB
2025-10-14 13:02
Registration Form
Statut
Polish 1.5 MB
2025-10-14 13:02
Registration Form
Rejestracja zmian statutu - Content (PL)
Polish 5.1 KB
2025-10-08 16:18
Board/Management Information
Oświadczenie
Polish 156.9 KB
2025-10-08 16:18
Board/Management Information
Oświadczenie
Polish 131.2 KB
2025-10-08 16:18
Board/Management Information
Powołanie osób nadzorujących - członków Rady Nadzorczej drugiej kadencji - Cont…
Polish 1.3 KB
2025-10-08 16:04
Board/Management Information
Rezygnacja Członka Rady Nadzorczej - Content (PL)
Polish 508 bytes
2025-10-08 15:53
Declaration of Voting Results & Voting Rights Announcements
Lista akcjonariuszy
Polish 51.0 KB

Automate Your Workflow. Get a real-time feed of all NanoGroup S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NanoGroup S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NanoGroup S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ARROWHEAD PHARMACEUTICALS, INC. Logo
Develops RNAi medicines to silence genes causing intractable cardiometabolic and pulmonary diseases.
United States of America
ARWR
ARS Pharmaceuticals, Inc. Logo
Develops the first FDA-approved, needle-free epinephrine spray for severe allergic reactions.
United States of America
SPRY
ARTELO BIOSCIENCES, INC. Logo
Develops lipid-signaling therapeutics for cancer, pain, anxiety, and depression.
United States of America
ARTL
Artiva Biotherapeutics, Inc. Logo
Develops allogeneic, off-the-shelf NK cell therapies for cancer and autoimmune diseases.
United States of America
ARTV
Ascelia Pharma Logo
Develops novel drugs for rare oncology, including an oral MRI contrast agent for cancer patients.
Sweden
ACE
Ascendis Pharma A/S Logo
Biopharma using proprietary TransCon® tech to develop therapies for rare diseases & oncology.
United States of America
ASND
ASCENTAGE PHARMA GROUP INTERNATIONAL Logo
Biopharma developing small-molecule drugs for cancer, HBV, and age-related diseases.
United States of America
AAPG
Specializes in hormone drugs for OB/GYN, urology, internal medicine, and animal health.
Japan
4886
Aspire Biopharma Holdings, Inc. Logo
Developing a nano-platform for rapid, sublingual delivery of reformulated medications.
United States of America
ASBP
ASSEMBLY BIOSCIENCES, INC. Logo
Clinical-stage biopharma developing small-molecule antivirals for herpes, HBV, and HDV.
United States of America
ASMB

Talk to a Data Expert

Have a question? We'll get back to you promptly.